Loading
A phase 2 trial of Electrochemotherapy in Breast cancer, run by Copenhagen University Hospital at Herlev, recorded as terminated on the registry.
Electrochemotherapy for Chest Wall Recurrence af Breast Cancer: Present Challenges and Future Prospects is a phase 2 interventional study registered as NCT00744653 by Copenhagen University Hospital at Herlev, with 17 participants recorded, started 2008-10 and due to reach its primary completion in 2010-11. Interventions recorded: Electrochemotherapy. Conditions recorded: Breast Cancer.
Linked to the technology Electrochemotherapy because the registry names it ("electrochemotherapy") among its interventions and Breast cancer among its conditions. Registry record only: no result has been read by an editor.
Numbers are from the trial as recorded here; see the source links in the table below. This is orientation, not medical advice: ask your team how closely the trial population matches you.
17 enrolled.
Figures from the ClinicalTrials.gov results section (first posted 2014-07-18), not from a publication
SourceFigures from the ClinicalTrials.gov results section (first posted 2014-07-18), not from a publication
SourceShares Electrochemotherapy and the tag pipeline.
Shares Electrochemotherapy and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.
Shares Breast cancer (all types) and the tag pipeline.